<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Medical-Device on Lionel Blog</title><link>https://hybridego.github.io/tags/medical-device/</link><description>Recent content in Medical-Device on Lionel Blog</description><generator>Hugo</generator><language>ko-KR</language><lastBuildDate>Wed, 15 Jul 2026 08:32:00 +0900</lastBuildDate><atom:link href="https://hybridego.github.io/tags/medical-device/index.xml" rel="self" type="application/rss+xml"/><item><title>오늘의 주식 후보 노트: 의료기기와 미용의료 실적 방어</title><link>https://hybridego.github.io/2026/07/15/stock-candidate-note-medical-device-aesthetics-defensive-growth/</link><pubDate>Wed, 15 Jul 2026 08:32:00 +0900</pubDate><guid>https://hybridego.github.io/2026/07/15/stock-candidate-note-medical-device-aesthetics-defensive-growth/</guid><description>&lt;h1 id="오늘의-주식-후보-노트-의료기기와-미용의료-실적-방어"&gt;오늘의 주식 후보 노트: 의료기기와 미용의료 실적 방어&lt;/h1&gt;
&lt;ul&gt;
&lt;li&gt;Current date: 2026-07-15&lt;/li&gt;
&lt;li&gt;Analysis target: 한국과 미국 주식 후보 6개&lt;/li&gt;
&lt;li&gt;Report mode: Candidate journal / public stock research notebook&lt;/li&gt;
&lt;li&gt;Data timestamp: 2026-07-15 08:32 KST 기준. 한국 시세는 네이버 모바일 종목 API의 2026-07-14 종가와 2026-07-15 장전 표시값, 미국 시세는 Nasdaq API의 2026-07-14 정규장 및 시간외 표시값 기준&lt;/li&gt;
&lt;li&gt;주요 출처: &lt;a href="https://www.cnbc.com/2026/07/13/stock-market-today-live-updates.html"&gt;CNBC 7월 14일 미국 시장 마감&lt;/a&gt;, &lt;a href="https://finance.yahoo.com/markets/stocks/articles/stock-market-news-july-7-100000088.html"&gt;Yahoo Finance 7월 7일 섹터 흐름&lt;/a&gt;, &lt;a href="https://www.koreabiomed.com/news/articleView.html?idxno=32293"&gt;Korea Biomedical Review - GLP-1 부작용과 K-미용의료&lt;/a&gt;, &lt;a href="https://biz.chosun.com/en/en-science/2026/07/03/MGXTHJLCYRATFJH22OHQE2R2JU/"&gt;ChosunBiz - KOSDAQ 우량 바이오와 미용의료 후보&lt;/a&gt;, &lt;a href="https://www.ajupress.com/view/20260706140470802"&gt;Aju Press - K-미용의료 해외 매출 전망&lt;/a&gt;, &lt;a href="https://kind.krx.co.kr/external/dst/irReference/18518/Classys%20IR%20Book_1Q26_Eng_vF_260513.pdf"&gt;Classys 1Q26 IR Book&lt;/a&gt;, &lt;a href="https://en.sedaily.com/news/2026/05/13/classys-posts-427-percent-operating-margin-on-brazilian"&gt;Seoul Economic Daily - Classys 1Q26 실적&lt;/a&gt;, &lt;a href="https://en.sedaily.com/news/2026/05/08/pharmaresearch-q1-operating-profit-jumps-28-percent-on"&gt;Seoul Economic Daily - PharmaResearch 1Q26 실적&lt;/a&gt;, &lt;a href="https://en.sedaily.com/culture/2026/05/07/hugel-posts-record-q1-earnings-on-46-percent-surge-in"&gt;Seoul Economic Daily - Hugel 1Q26 실적&lt;/a&gt;, &lt;a href="https://news.bostonscientific.com/2026-04-22-Boston-Scientific-announces-results-for-first-quarter-2026"&gt;Boston Scientific 1Q26 실적 발표&lt;/a&gt;, &lt;a href="https://investors.dexcom.com/news/news-details/2026/Dexcom-Reports-First-Quarter-2026-Financial-Results/default.aspx"&gt;Dexcom 1Q26 실적 발표&lt;/a&gt;, &lt;a href="https://www.sec.gov/Archives/edgar/data/310764/000031076426000025/sykex991earningsq12026.htm"&gt;Stryker 1Q26 SEC 8-K&lt;/a&gt;, &lt;a href="https://m.stock.naver.com/domestic/stock/214150"&gt;네이버 금융 클래시스&lt;/a&gt;, &lt;a href="https://m.stock.naver.com/domestic/stock/214450"&gt;네이버 금융 파마리서치&lt;/a&gt;, &lt;a href="https://m.stock.naver.com/domestic/stock/145020"&gt;네이버 금융 휴젤&lt;/a&gt;, &lt;a href="https://api.nasdaq.com/api/quote/BSX/info?assetclass=stocks"&gt;Nasdaq BSX&lt;/a&gt;, &lt;a href="https://api.nasdaq.com/api/quote/DXCM/info?assetclass=stocks"&gt;Nasdaq DXCM&lt;/a&gt;, &lt;a href="https://api.nasdaq.com/api/quote/SYK/info?assetclass=stocks"&gt;Nasdaq SYK&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;blockquote&gt;
&lt;p&gt;이 글은 투자 추천이 아니라 공개자료로 남기는 후보 선별 기록이다. 의료기기와 미용의료는 경기 방어적으로 보이지만 규제, 병원 투자, 보험 수가, 중국과 미국 승인 일정에 따라 실적이 흔들릴 수 있다. 테마가 조용하다고 해서 자동으로 싸거나 안전한 것은 아니다.&lt;/p&gt;</description></item></channel></rss>